Re: randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido: north central cancer treatment group protocol N02C3.
Byron
B
Jones
Scott
S
Haughie
D000279:Administration, Cutaneous; D018592:Cross-Over Studies; D003627:Data Interpretation, Statistical; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects*; D009369:Neoplasms / Q000523:psychology*; D017741:Survivors; D013739:Testosterone / Q000008:administration & dosage*
D013739:Testosterone